Community/Retail

Research reveals low-dose cannabinoids, like THC, may enhance serotonin levels and combat chronic inflammation in HIV patients, offering new treatment possibilities.

Implementing a best practice advisory into physicians’ electronic health records improved lipid therapy initiation and diagnoses of hyperlipidemia and hypercholesterolemia.

Shivang Joshi, MD, MPH, RPh, FAHS, outlines essential counseling points on dosing, timing, contraindications, and rebound headache risks when dispensing Symbravo.

A new rapid test for pertussis enables quick diagnosis in as little as 15 minutes, addressing rising whooping cough cases.

The pneumococcal 13-valent conjugate vaccine (PCV13) was effective at preventing pneumococcal lower respiratory tract infection (LRTI) in older patients from Thailand.

A 3-month resistance exercise program helped improve walking distance, grip strength, and other parameters of physical health in patients with long COVID.

Depression and cardiometabolic disease share hormonal, inflammatory, and behavioral pathways requiring integrated pharmacist-led recognition and management.

The FDA approves Amneal's albuterol sulfate inhalation aerosol, enhancing access to vital asthma and COPD treatments for millions of Americans.

Shivang Joshi, MD, MPH, RPh, FAHS, discusses how Symbravo’s multimechanistic fixed-dose design may address gaps in acute migraine therapy for patients who do not respond to single-agent treatments.

The National Lipid Association aims to enhance the science and practice of lipidology and promote optimal cardiometabolic health.

New research uncovers diverse tumor subgroups in triple-negative breast cancer, paving the way for personalized treatment strategies and improved patient outcomes.

In a phase 2 trial, the unimolecular agonist of GLP-1 and amylin induced major reductions in weight loss and hemoglobin A1c in patients with type 2 diabetes.

Examining Trends From Past Respiratory Virus Seasons Can Inform New Vaccination Strategies

Coffee Consumption May Reduce Depression Risk and Boost Mood, Offering Potential Benefits for Mental Health

Investigators determined a series of risk factors that can lead to complicated pneumococcal bacteremia, including older age and key comorbidities.

Pharmacists Can Incorporate the New Hypertension Guidelines Into Their Medication Therapy Management Practices

GLP-1 receptor agonists expand treatment options for diabetes, weight loss, and more, showing promise in heart failure, kidney disease, and neuroprotection.

Research funding disruptions at the National Institutes of Health (NIH) impact clinical trials, threatening treatment options for patients and highlighting the critical role of pharmacists in care continuity.

New vaccine developments for Crimean-Congo hemorrhagic fever offer hope for prevention, highlighting pharmacists' crucial role in future vaccination efforts.

Post-pandemic, invasive pneumococcal disease cases rise among youth due to declining vaccination rates, highlighting urgent public health concerns.

Tech-Check-Tech Improves Workflow and Allows Pharmacists to Focus on Clinical Responsibilities